During the past decade, Washington University School of Medicine-Dermatology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington University School of Medicine-Dermatology" #1 sponsor was "Aristea Therapeutics, Inc." with 1 trials, followed by "Botanix Pharmaceuticals" with 1 trials sponsored, "Lutris Pharma Ltd." with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Provectus Biopharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Washington University School of Medicine-Dermatology" are "Acne Vulgaris" (1 trials), "Alopecia Areata" (1 trials), "Cutaneous Melanoma" (1 trials), "EGFR Inhibitor Induced Acneiform Lesions" (1 trials) and "Palmoplantar Pustulosis" (1 trials). Many other conditions were trialed in "Washington University School of Medicine-Dermatology" in a lesser frequency.

Most popular intervention types in "Washington University School of Medicine-Dermatology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BTX 1503" (1 trials), "Dacarbazine, temozolomide or talimogene laherparepvec" (1 trials), "LUT014" (1 trials) and "PF-06651600" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington University School of Medicine-Dermatology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Washington University School of Medicine-Dermatology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Washington University School of Medicine-Dermatology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Washington University School of Medicine-Dermatology, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".